Special Residual Risk: A Focus on Triglycerides, Part 1 – August 2023
In this special episode on Residual Risk: A Focus on Triglycerides, our host, Dr. Neil Skolnik will discuss Residual Risk, Triglycerides and how to reduce residual risk with Dr. Christie Ballantyne, Director of the Center for Cardiometabolic Disease Prevention, Baylor College of Medicine. This special episode is supported by an independent educational grant from Amarin. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Christie Ballantyne. Dr. Ballant...
Source: Diabetes Core Update - August 15, 2023 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Niacin for people with or without established cardiovascular disease
Heart attack and stroke are the most common causes of death, illness, disability and reduced quality of life in industrialised countries, and several Cochrane Reviews look at ways to prevent these cardiovascular events. A new review from June 2017 looks at the evidence for a B-vitamin called niacin. One of the reviews' authors, Matthias Briel from Basel Institute for Clinical Epidemiology and Biostatistics in Switzerland, outlines the findings in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 20, 2018 Category: General Medicine Authors: Cochrane Source Type: podcasts
Apr 22 Cardiology News
The FDA ’ s decision on niacin and fenofibric acid, inappropriate carotid screening, same day discharge PCI, gender differences in testing for CAD, and obesity in adolescents are reviewed this week. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 22, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts
Is Niacin Done?
The latest research seems to settle any question of a role for niacin in the management of hyperlipidemia. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - December 18, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Niacin With Statins? No Dice.
Wilbert Aronow comments on the trial that slammed the door on niacin for lipid-lowering. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - September 19, 2014 Category: Primary Care Authors: Medscape Source Type: podcasts
#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 13, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Choosing wisely now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol in (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 1, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#174: Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury
Niacin/laropiprant products to be suspended; JNC 8, ATP 4 guidelines; new meta-analysis on sugar sparks old debate; two antihypertensives plus NSAID ups risk of acute kidney injury (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - January 18, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#38: HDL cholesterol, niacin, and AIM-HIGH with Dr Jim Stein
Is the concept of raising HDL cholesterol still pertinent in an era of well-controlled LDL levels via statin therapy? To address this question, our guest Dr Jim Stein reviews what evidence exists to indicate low HDL cholesterol may predict heart disease.. (Source: The Bob Harrington Show)
Source: The Bob Harrington Show - July 6, 2011 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
